IN SB0221

State health commissioner must issue standing orders allowing pharmacists to test for COVID-19, Group B streptococcus, RSV, and influenza using FDA-approved, CLIA-waived point-of-care tests

Pharmacists may prescribe and dispense medications for diagnosed conditions when the medication is FDA-authorized and included on a protocol list established by the Indiana Board of Pharmacy

Pharmacists must complete ACPE-approved continuing education, maintain records for at least 7 years, report positive test results to the health department, and provide patients written guidance to follow up with their primary care provider

Pharmacy technicians and interns may collect specimens and administer tests under direct pharmacist supervision, with the pharmacist responsible for test interpretation and prescribing

Pharmacists acting in good faith under the standing order receive civil immunity unless their actions constitute gross negligence, willful misconduct, or intentional wrongdoing; effective July 1, 2026